Delivery Order SPE2DR25D2007-SPE2DR26FM29D
- Not listed
- The Defense Logistics Agency awarded a $1,707.46 delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100 count). This firm fixed-price contract, which carries an ultimate completion date of December 11, 2025, represents a non-set-aside competitive award to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Dextroamphetamine-Amphetamine 25 mg capsules (100-count) with a ceiling value of $1,059.94 and a completion date of December 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100 count) with a contract ceiling value of $1,973.26. This firm fixed-price delivery order, with an ultimate completion date of December 10, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was competitively awarded through an open procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100 count) with a ceiling value of $1,525.55. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by December 17, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,548.09 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 12, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Dextroamphetamine-Amphetamine 15 mg capsules (100 count) with a ceiling value of $1,131.09. This is a firm fixed price delivery order with no set-aside designation, issued competitively. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 15, 2025. This delivery order is...
- The Defense Logistics Agency awarded a Delivery Order valued at $1,498.56 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100 count) on November 5, 2025, with completion scheduled for November 6, 2025. This non-competitive, firm fixed-price delivery order was fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, representing a routine pharmaceutical procurement under the company's existing contract vehicle with DLA. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Dextroamphetamine-Amphetamine 15 mg capsules (100-count units) with a ceiling value of $1,460.67. This is a firm fixed-price delivery order with an ultimate completion date of November 19, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count unit) with a ceiling value of $1,241.68. This competitively awarded, firm fixed-price contract is classified as a delivery order with an ultimate completion date of December 15, 2025, and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. No set-aside designation was utilized...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 15 mg capsules (100-count units) with a ceiling value of $1,153.53. The contract, awarded on December 3, 2025, with an ultimate completion date of December 4, 2025, was issued on a firm fixed-price basis with no set-aside designation, indicating competitive award. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D2007Indefinite Delivery Contract
- SPE2DR25D2007-SPE2DR26FM29DDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100 count) with a ceiling value of $4,282.45. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order is scheduled for ultimate completion by December 19, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency. The company's DLA Troop Support Medical contract functions as a comprehensive global pharmaceutical support vehicle enabling supply of a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. This delivery order represents a routine pharmaceutical procurement transaction consistent with AmerisourceBergen's established role as a primary supplier within the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 12/17/25 |